1,023 research outputs found
Recommended from our members
Islet β cell mass in diabetes and how it relates to function, birth, and death
In type 1 diabetes (T1D) β cell mass is markedly reduced by autoimmunity. Type 2 diabetes (T2D) results from inadequate β cell mass and function that can no longer compensate for insulin resistance. The reduction of β cell mass in T2D may result from increased cell death and/or inadequate birth through replication and neogenesis. Reduction in mass allows glucose levels to rise, which places β cells in an unfamiliar hyperglycemic environment, leading to marked changes in their phenotype and a dramatic loss of glucose-stimulated insulin secretion (GSIS), which worsens as glucose levels climb. Toxic effects of glucose on β cells (glucotoxicity) appear to be the culprit. This dysfunctional insulin secretion can be reversed when glucose levels are lowered by treatment, a finding with therapeutic significance. Restoration of β cell mass in both types of diabetes could be accomplished by either β cell regeneration or transplantation. Learning more about the relationships between β cell mass, turnover, and function and finding ways to restore β cell mass are among the most urgent priorities for diabetes research
Somatostatin: Diverse Physiological Roles and Therapeutic Implications
In its brief lifetime as a known peptide, somatostatin has provided a truly remarkable story filled with surprising developments from unexpected quarters. The foundation was set in 1969, when Krulich and McCann reported that fractions of a crude hypothalamic extract inhibited the secretion of growth hormone. In 1973, Guillemin\u27s laboratory reported the sequence and synthesis of a fourteen amino acid peptide with the same inhibitory effect. It occurs in both a cyclic and linear form, each displaying equal biological activity. Somatostatin was assigned as its name, but it is also commonly referred to as growth hormone release inhibitory factor (GHRIF) or somatotropin-release inhibiting factor (SRIF)
English historical novels on the first century A.D. as reflecting the trends of religious thought during the nineteenth and twentieth centuries
1. The Outside Tradition •
2. The Novel on Early Christian Times
1820-1850 •
3. The Early Christian Novel Ehters
Controversy •
4. The Imaginative Approach to the New
Testament Outside the Novel •
5. The Early Christian Romancers,
1860-1900 •
6. Modernism, and the Reconstruction of
a Point of view Towards Christian
Origins •
7. The First Two Decades of the Twentieth
Century •
8. Novels, mostly of Scepticism,
1920-1939 •
9. Novels, chiefly of Belief, 1940-1955 •
10. The Continuing Outside Traditio
Recommended from our members
β-cell dedifferentiation in diabetes is important, but what is it?
This commentary discusses the concept of β-cell dedifferentiation in diabetes, which is important but not well defined. A broad interpretation is that a state of differentiation has been lost, which means changes in gene expression as well as in structural and functional elements. Thus, a fully mature healthy β cell will have its unique differentiation characteristics, but maturing cells and old β cells will have different patterns of gene expression and might therefore be considered as dedifferentiated. The meaning of dedifferentiation is now being debated because β cells in the diabetic state lose components of their differentiated state, which results in severe dysfunction of insulin secretion. The major cause of this change is thought to be glucose toxicity (glucotoxicity) and that lowering glucose levels with treatment results in some restoration of function. An issue to be discussed is whether dedifferentiated β cells return to a multipotent precursor cell phenotype or whether they follow a different pathway of dedifferentiation
Recommended from our members
Stem cell approaches for diabetes: towards beta cell replacement
Stem cells hold great promise for pancreatic beta cell replacement therapy for diabetes. In type 1 diabetes, beta cells are mostly destroyed, and in type 2 diabetes beta cell numbers are reduced by 40% to 60%. The proof-of-principle that cellular transplants of pancreatic islets, which contain insulin-secreting beta cells, can reverse the hyperglycemia of type 1 diabetes has been established, and there is now a need to find an adequate source of islet cells. Human embryonic stem cells can be directed to become fully developed beta cells and there is expectation that induced pluripotent stem (iPS) cells can be similarly directed. iPS cells can also be generated from patients with diabetes to allow studies of the genomics and pathogenesis of the disease. Some alternative approaches for replacing beta cells include finding ways to enhance the replication of existing beta cells, stimulating neogenesis (the formation of new islets in postnatal life), and reprogramming of pancreatic exocrine cells to insulin-producing cells. Stem-cell-based approaches could also be used for modulation of the immune system in type 1 diabetes, or to address the problems of obesity and insulin resistance in type 2 diabetes. Herein, we review recent advances in our understanding of diabetes and beta cell biology at the genomic level, and we discuss how stem-cell-based approaches might be used for replacing beta cells and for treating diabetes
Unreported summary statistics in trial publications and risk of bias in stroke rehabilitation systematic reviews: an international survey of review authors and examination of practical solutions
Induction of remission in diabetes by lowering blood glucose
As diabetes continues to grow as major health problem, there has been great progress in understanding the important role of pancreatic beta-cells in its pathogenesis. Diabetes develops when the normal interplay between insulin secretion and the insulin sensitivity of target tissues is disrupted. With type 2 diabetes (T2D), glucose levels start to rise when beta-cells are unable to meet the demands of insulin resistance. For type 1 diabetes (T1D) glucose levels rise as beta-cells are killed off by autoimmunity. In both cases the increased glucose levels have a toxic effect on beta-cells. This process, called glucose toxicity, has a major inhibitory effect on insulin secretion. This beta-cell dysfunction can be reversed by therapies that reduce glucose levels. Thus, it is becoming increasingly apparent that an opportunity exists to produce a complete or partial remission for T2D, both of which will provide health benefit
Some exact solutions in the one-dimensional unsteady motion of a gas
In this thesis, we present certain exact solutions of the mathematical equations governing the one-dimensional unsteady flow of a compressible fluid. In Chapter 2 we introduce the well-known simplification of the equations (1.1.10), (1.1.11) and (1.1.12) which occurs when the entropy is assumed to be constant, and conditions for parching solutions of the equations along characteristics are obtained. These results are used to generalise a problem solved by Mackie. In chapter 3 we meet the concept of a shook, and exact solutions are obtained for two problems in which shocks occur in non-uniform flows. In chapter 4 the case of waves in shallow water which has differential equations similar to those of gas flow is discussed. The results of the previous section are applied to this case and a problem attacked which permits a comparison to be made of the results obtained by this theory and a simpler linearized theory. Finally in chapter 5 we examine a method introduced by Martin for dealing with certain non-isentropic flows. Some new exact solutions of non-isentropic flows are thus obtained
Recommended from our members
β-Cell Growth and Regeneration: Replication is Only Part of the Story
- …